Home » Stocks » AIKI

AIkido Pharma, Inc. (AIKI)

Stock Price: $0.950 USD -0.019 (-1.93%)
Updated Jun 21, 2021 11:50 AM EDT - Market open
Market Cap 86.73M
Revenue (ttm) 9,000
Net Income (ttm) -7.97M
Shares Out 60.28M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 21
Last Price $0.950
Previous Close $0.969
Change ($) -0.019
Change (%) -1.93%
Day's Open 0.970
Day's Range 0.930 - 0.970
Day's Volume 1,013,240
52-Week Range 0.466 - 2.550

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, June 4, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June...

2 weeks ago - PRNewsWire

New York, New York--(Newsfile Corp. - May 20, 2021) -  PCG Digital -- Anthony Hayes is an optimist, with good reason. The CEO of AIkido Pharmaceuticals (NASDAQ: AIKI), according to the company's Q1 repo...

1 month ago - Newsfile Corp

NEW YORK, May 20, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Phase 1 testing data will be presented at the 2021 ASCO Annual Meeting June 4, 2...

1 month ago - PRNewsWire

New York, New York--(Newsfile Corp. - May 19, 2021) - PCG Digital -- Continuing the barrage of good-news announcements that began with its first quarter results and strong balance sheet reports, Alkido ...

1 month ago - Newsfile Corp

These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments. The post 7 Reddit Penny Stocks Promising to Cure Cancer appeared first on I...

Other stocks mentioned: ATNM, ATOS, BNGO, CTIC, IMMP, ONTX
1 month ago - InvestorPlace

New York, New York--(Newsfile Corp. - May 13, 2021) - AIkido Pharma Inc. (NASDAQ: AIKI) today announced that Darrell G. Dotson, Vice President and General Counsel will be attending the Q2 Virtual Invest...

1 month ago - Newsfile Corp

New York, New York--(Newsfile Corp. - May 13, 2021) - PCG Digital -- Things seem to be heating up for (NASDAQ: AIKI) with a near term potential catalyst quickly approaching this quarter and several othe...

1 month ago - Newsfile Corp

NEW YORK, May 11, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") reported financial results for the first quarter ended March 31, 2021 and provided a corporate update...

1 month ago - PRNewsWire

Biotech penny stocks are back in focus; should these 3 be on your watchlist? The post Top Biotech Penny Stocks on Reddit?

Other stocks mentioned: ATOS, DFFN
1 month ago - PennyStocks

NEW YORK, April 26, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company's Scientific Advisory Board. "Dr. F...

1 month ago - PRNewsWire

Penny stocks on Robinhood are a big focus for Reddit traders in April The post 4 Reddit Penny Stocks To Buy On Robinhood For Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Inf...

Other stocks mentioned: BBI, KIQ, OGEN
1 month ago - PennyStocks

Biotech stocks are more popular than ever; here are 3 to watch under $5 The post Biotech Penny Stocks To Buy? 3 to Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other stocks mentioned: BBI, BIOL
1 month ago - PennyStocks

NEW YORK, April 22, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company has withdrawn its S-1 Registration Statement that was previously f...

1 month ago - PRNewsWire

Biotech penny stocks are all the rage; should you check these four out? The post 4 Biotech Penny Stocks To Watch That Are Heating Up This Month appeared first on Penny Stocks to Buy, Picks, News and Inf...

Other stocks mentioned: ITRM, OVID, TTOO
2 months ago - PennyStocks

NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conduc...

2 months ago - PRNewsWire

Aikido Pharma Inc (NASDAQ: AIKI) has been granted an exclusive sublicense to technology related to the use of the central nervous system (CNS) homing peptides to treat neuroinflammatory disease in cance...

2 months ago - Benzinga

NEW YORK, April 7, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of...

2 months ago - PRNewsWire

NEW YORK, April 5, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided a business update. Anthony Hayes, CEO of AIkido Pharma, stated, "AIkido's primary foc...

2 months ago - PRNewsWire

NEW YORK, March 29, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it is sponsoring psychedelic research at the Mount Sinai Center for Psychedeli...

2 months ago - PRNewsWire

NEW YORK, March 12, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matt Frieman appeared on the video podcast This Week in Virology, segment ...

3 months ago - PRNewsWire

NEW YORK, Feb. 25, 2021 /PRNewswire/ -- The emergence of psychedelics as a mental health solution and as a legitimate industry has been one of the most radical market developments that we have seen in d...

Other stocks mentioned: CMPS
3 months ago - PRNewsWire

NEW YORK, Feb. 23, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the underwriter of its previously announced bought deal offering of common stoc...

3 months ago - PRNewsWire

NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46,875,000 s...

4 months ago - PRNewsWire

Aikido Pharma Inc (NASDAQ: AIKI) has increased the size of the previously announced public offering to 46.8 million shares at $1.60 per share, with gross proceeds of $75 million. The previous offering i...

4 months ago - Benzinga

NEW YORK, Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the underwriter has agreed to increase the size of the previousl...

4 months ago - PRNewsWire

NEW YORK, Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under ...

4 months ago - PRNewsWire

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that on January 22, 2021, the Company received a letter from the Listing Qualificati...

4 months ago - PRNewsWire

Alkido Pharma (NASDAQ: AIKI) shares are trading higher after the company announced it executed a Patent License Agreement for technology that covers the use of psilocybin for cancer applications. AIkido...

Other stocks mentioned: CHNG, ISR
5 months ago - Benzinga

Shares of AIKI stock are skyrocketing after Aikido Pharma announced a new patent agreement for the use of psilocybin for cancer treatments. The post Aikido Pharma News: Why AIKI Stock Is Soaring Today a...

5 months ago - InvestorPlace

NEW YORK, Jan. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Patent License Agreement for technology that covers the u...

5 months ago - PRNewsWire

NEW YORK, Dec. 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the publication of positive results from its Artificial Intelligence/Machine Learning...

6 months ago - PRNewsWire

NEW YORK, Nov. 20, 2020 /PRNewswire/ -- AIkido Pharma Inc. (the "Company" or "AIkido") (NASDAQ: AIKI) today announced the results from the virtual 2020 Annual Meeting of Stockholders (the "Meeting") hel...

7 months ago - PRNewsWire

NEW YORK, Oct. 28, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its preclinical work on its next-generation chemotherapeutic, DHA-dFdC, ...

7 months ago - PRNewsWire

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) today announced that its work with research partner, Cogia BioTech LTD (www.cogia.de), has delivered several key updates on eff...

9 months ago - PRNewsWire

NEW YORK, Sept. 11, 2020 /PRNewswire/ -- AIkido Pharma Inc.

9 months ago - PRNewsWire

NEW YORK, Sept. 11, 2020 /PRNewswire/ -- AIkido Pharma Inc.

9 months ago - PRNewsWire

NEW YORK, Aug. 14, 2020 /PRNewswire/ -- AIkido Pharma Inc.

10 months ago - PRNewsWire

NEW YORK, Aug. 11, 2020 /PRNewswire/ -- AIkido Pharma Inc.

10 months ago - PRNewsWire

NEW YORK, July 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its effort to identify compounds to potentially address the COVID-19 pand...

11 months ago - PRNewsWire

Shares of nano-cap biotech Aikido Pharma Inc (NASDAQ: AIKI), are ripping higher following an announcement concerning worldwide licensing of an antiviral platform.

1 year ago - Benzinga

Aikido Pharma Inc. (NASDAQ: AIKI) is not necessarily a household name, but on Tuesday its shares made waves.

1 year ago - 24/7 Wall Street

About AIKI

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus,... [Read more...]

Industry
Biotechnology
Founded
1967
CEO
Anthony Hayes
Employees
4
Stock Exchange
NASDAQ
Ticker Symbol
AIKI
Full Company Profile

Financial Performance

Financial Statements